CD4 is surface molecule that serves as the receptor for human immunodeficiency virus (HIV), the causative agent of AIDS. We have focused on two areas related to CD4 and HIV: 1) Mechanisms of membrane fusion mediated by the interaction of CD4 with the HIV-1 envelope glycoprotein (env). One goal of this work is to identify regions of each molecule involved in fusion, and to characterize fusion-related changes in env structure induced upon interaction with CD4. Site- directed mutagenesis studies indicated that CD4 molecules containing a wide variety of mutations in the CDR3 region efficiently support membrane fusion. Mutation of this region also had no effect on the ability of soluble CD4 to induce a specific structural change in env (gp120 stripping). These results challenge the prevailing notion that the CDR3 region plays a critical role in the fusion process. Furthermore, a region of gp120 (V3) believed to participate in fusion appears not to be involved in CD4-induced gp120 stripping, based on studies with fusion-defective V3 mutants. A second goal is to identify additional molecular components involved in fusion. We have demonstrated that human cells can provide to CD4-expressing non-human cells a component(s) which is essential for env-mediated membrane fusion. The critical involvement of calcium ions in the fusion process has also been demonstrated. We are actively developing new systems and assays to study the fusion process, to be applied towards mechanistic studies of membrane fusion and the selective tropism of different HIV isolates for different CD4+ cell types.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000538-05
Application #
3790797
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Salzwedel, Karl; Berger, Edward A (2009) Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: a general property of the functional trimer. Retrovirology 6:75
Berger, Edward A; Alkhatib, Ghalib (2007) HIV gp120 interactions with coreceptors: insights from studies with CCR5-based peptides. Eur J Med Res 12:403-7
Alkhatib, Ghalib; Berger, Edward A (2007) HIV coreceptors: from discovery and designation to new paradigms and promise. Eur J Med Res 12:375-84
Lusso, Paolo; Earl, Patricia L; Sironi, Francesca et al. (2005) Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. J Virol 79:6957-68
Lagenaur, Laurel A; Berger, Edward A (2005) An anti-HIV microbicide comes alive. Proc Natl Acad Sci U S A 102:12294-5
Agrawal, Lokesh; VanHorn-Ali, Zainab; Berger, Edward A et al. (2004) Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5. Blood 103:1211-7
Dey, Barna; Del Castillo, Christie S; Berger, Edward A (2003) Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor. J Virol 77:2859-65
Farber, Joshua M; Berger, Edward A (2002) HIV's response to a CCR5 inhibitor: I'd rather tighten than switch! Proc Natl Acad Sci U S A 99:1749-51
McHugh, Louise; Hu, Stella; Lee, B K et al. (2002) Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis. J Biol Chem 277:34383-90
Schito, M L; Kennedy, P E; Kowal, R P et al. (2001) A human immunodeficiency virus-transgenic mouse model for assessing interventions that block microbial-induced proviral expression. J Infect Dis 183:1592-600

Showing the most recent 10 out of 17 publications